Literature DB >> 22561341

In vivo detection of experimental optic neuritis by pupillometry.

Kenneth S Shindler1, Karen Revere, Mahasweta Dutt, Gui-Shuang Ying, Daniel C Chung.   

Abstract

Optic neuritis is an inflammatory demyelination of optic nerve often occurring in multiple sclerosis (MS) patients. Mice with experimental autoimmune encephalomyelitis (EAE), an MS model, develop optic neuritis, but it is detected histologically after sacrifice, limiting the ability to monitor progression or treatment in vivo. We examined whether pupillary light responses measured by pupillometry can identify eyes with optic neuritis in EAE mice. C57BL/6 mice were exposed to unilateral light flashes of increasing intensity at 10 s intervals (4.7, 37, and 300 μW/cm(2)). Pupillary responses were recorded with a commercially available pupillometer. EAE was then induced by immunization with myelin oligodendrocyte glycoprotein. Pupillometry was repeated up to 17 days post-immunization, and responses were correlated with optic nerve inflammation. By day 17 post-immunization, 90% of EAE eyes had optic nerve inflammation. EAE eyes had significantly reduced pupillary constriction compared to control eyes. Mice exhibited more than a 25% decrease in pupillary constriction in at least one eye by days 13-15 post-immunization. In some eyes, pupil responses decreased prior to onset of detectable inflammation. Results show that pupillometry detects decreased optic nerve function in experimental optic neuritis, even in the absence of histological detection. Measuring pupillary constriction allows in vivo identification and functional assessment of eyes with optic neuritis that will be useful in evaluating potential therapies over time. Furthermore, results demonstrate that decreased visual function occurs early in optic neuritis, before optic nerve inflammation reaches its peak level.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561341      PMCID: PMC3923364          DOI: 10.1016/j.exer.2012.04.005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  23 in total

Review 1.  Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration.

Authors:  Andreas Wenzel; Christian Grimm; Marijana Samardzija; Charlotte E Remé
Journal:  Prog Retin Eye Res       Date:  2004-11-11       Impact factor: 21.198

2.  Retinal architecture predicts pupillary reflex metrics in MS.

Authors:  A R Salter; A Conger; T C Frohman; R Zivadinov; E Eggenberger; P Calabresi; G Cutter; L Balcer; E M Frohman
Journal:  Mult Scler       Date:  2008-12-17       Impact factor: 6.312

3.  Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.

Authors:  Muriel Hobom; Maria K Storch; Robert Weissert; Katharina Maier; Anand Radhakrishnan; Birgit Kramer; Mathias Bähr; Ricarda Diem
Journal:  Brain Pathol       Date:  2004-04       Impact factor: 6.508

4.  Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis.

Authors:  Mahasweta Dutt; Philomela Tabuena; Elvira Ventura; Abdolmohamad Rostami; Kenneth S Shindler
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

5.  Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.

Authors: 
Journal:  Arch Neurol       Date:  2008-06

6.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

Authors:  R W Beck; P A Cleary; M M Anderson; J L Keltner; W T Shults; D I Kaufman; E G Buckley; J J Corbett; M J Kupersmith; N R Miller
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

7.  Pupillary function in early multiple sclerosis.

Authors:  Jukka Surakka; Juhani Ruutiainen; Anders Romberg; Pauli Puukka; Erkki Kronholm; Hannu Karanko
Journal:  Clin Auton Res       Date:  2008-05-06       Impact factor: 4.435

8.  Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.

Authors:  Kenneth S Shindler; Elvira Ventura; Mahasweta Dutt; Abdolmohamad Rostami
Journal:  Exp Eye Res       Date:  2008-06-03       Impact factor: 3.467

9.  Pupillometry in mice: sex and strain-dependent phenotypes of pupillary functioning.

Authors:  Francis Anthony Michael Manno
Journal:  Optom Vis Sci       Date:  2009-07       Impact factor: 1.973

10.  Melanopsin signalling in mammalian iris and retina.

Authors:  T Xue; M T H Do; A Riccio; Z Jiang; J Hsieh; H C Wang; S L Merbs; D S Welsbie; T Yoshioka; P Weissgerber; S Stolz; V Flockerzi; M Freichel; M I Simon; D E Clapham; K-W Yau
Journal:  Nature       Date:  2011-11-02       Impact factor: 49.962

View more
  13 in total

1.  Pupillary light response after cataract surgery in healthy patients.

Authors:  Ken Hayashi; Motoaki Yoshida; Sosuke Ishiyama; Akira Hirata
Journal:  Jpn J Ophthalmol       Date:  2021-05-11       Impact factor: 2.447

2.  Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets.

Authors:  Vamshi K Nimmagadda; Christopher T Bever; Narasimha R Vattikunta; Saifi Talat; Vakas Ahmad; Naveen K Nagalla; David Trisler; Susan I V Judge; Walter Royal; Krish Chandrasekaran; James W Russell; Tapas K Makar
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

3.  SIRT1 promotes RGC survival and delays loss of function following optic nerve crush.

Authors:  Ling Zuo; Reas S Khan; Vivian Lee; Kimberly Dine; Wen Wu; Kenneth S Shindler
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-26       Impact factor: 4.799

4.  Effects of Varying Intranasal Treatment Regimens in ST266-Mediated Retinal Ganglion Cell Neuroprotection.

Authors:  Reas S Khan; Kimberly Dine; Howard Wessel; Larry Brown; Kenneth S Shindler
Journal:  J Neuroophthalmol       Date:  2019-06       Impact factor: 3.042

5.  Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.

Authors:  Zoe Fonseca-Kelly; Mayssa Nassrallah; Jorge Uribe; Reas S Khan; Kimberly Dine; Mahasweta Dutt; Kenneth S Shindler
Journal:  Front Neurol       Date:  2012-05-24       Impact factor: 4.003

6.  Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.

Authors:  Sheryl L Herrera; Vanessa L Palmer; Heather Whittaker; Blair Cardigan Smith; Annie Kim; Angela E Schellenberg; Jonathan D Thiessen; Richard Buist; Marc R Del Bigio; Melanie Martin
Journal:  Magn Reson Insights       Date:  2014-11-09

7.  Development and Pre-Clinical Evaluation of Recombinant Human Myelin Basic Protein Nano Therapeutic Vaccine in Experimental Autoimmune Encephalomyelitis Mice Animal Model.

Authors:  Medhat A Al-Ghobashy; Aliaa N ElMeshad; Rania M Abdelsalam; Mohammed M Nooh; Muhammad Al-Shorbagy; Götz Laible
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

8.  Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model.

Authors:  Reas S Khan; Kimberly Dine; Bailey Bauman; Michael Lorentsen; Lisa Lin; Helayna Brown; Leah R Hanson; Aleta L Svitak; Howard Wessel; Larry Brown; Kenneth S Shindler
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

9.  Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model.

Authors:  Lioba Horstmann; Heiko Schmid; André P Heinen; Florian C Kurschus; H Burkhard Dick; Stephanie C Joachim
Journal:  J Neuroinflammation       Date:  2013-10-04       Impact factor: 8.322

10.  Clinical Utility of an Automated Pupillometer in Patients with Acute Brain Lesion.

Authors:  Jeong Goo Park; Chang Taek Moon; Dong Sun Park; Sang Woo Song
Journal:  J Korean Neurosurg Soc       Date:  2015-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.